Professor Alastair Noyce, BMedSci, MB BS, MSc, MRCP, PhD, FHEA

Profile

I am a Professor in Neurology and Neuroepidemiology in the Centre for Preventive Neurology (CPN), in the Wolfson Institute of Population Health, Queen Mary University of London (QMUL). I am the deputy lead for the CPN and a Consultant Neurologist at Barts Health NHS Trust.

I graduated from Barts and the London (QMUL) in 2007 and I pursued integrated training via the Foundation Academic Programme and an NIHR Academic Clinical Fellowship at UCL. Between 2012-2016 I undertook a PhD in Neuroscience at UCL and between 2014-2016 I undertook an MSc in Epidemiology at London School of Hygiene and Tropical Medicine. I re-joined QMUL and the PNU in 2017 to lead the Parkinson’s programme of work.

My research interests are Parkinson’s disease and other neurodegenerative disorders, particularly early identification and epidemiological aspects, including environmental, clinical and genetic determinants. I am the co-principal investigator of the PREDICT-PD study, principal investigator for the East London Parkinson’s Disease project and chief investigator for the Access-PD study.

I am a member of the International Parkinson and Movement Disorder Society (MDS). I graduated from the MDS LEAP leadership programme in 2020, and then became a member of the faculty for the LEAP, teaching leadership skills to early career movement disorders specialists around the world. I am the Chair of the MDS Epidemiology Study Group, a member of the MDS Early Onset PD Study Group and the Equality of Access to Care Committee. I on the Global Parkinson’s Genetics Program (GP2) and lead two of its working groups, focusing on Training and Networking and Prodromal PD. I am Associate Editor for the Journal of Parkinson’s Disease.

Away from neurodegenerative disease, I am interested in the emerging link between recreational use of nitrous oxide (laughing gas) and neurological harm. I have led the drafting of national guidance for managing the range of neurological conditions associated with nitrous oxide, as well as describing the clinical manifestations in patients in order to raise awareness amongst healthcare workers.

Research

Research Interests:

Neurology

Epidemiology

Genetics

Predictive models

Clinical research

Publications

• Sanyaolu AO, Mohamed W, Makarious MB et al. (2025). Chapter 4 Mendelian randomization and Parkinson’s disease. nameOfConference

  
  

  DOI: 10.1016/b978-0-443-13550-7.00006-9

  
  

  QMRO: qmroHref
• Kim JJ, Bandres-Ciga S, Heilbron K et al. (publicationYear). Bidirectional relationship between olfaction and Parkinson’s disease. nameOfConference

  
  

  DOI: 10.1038/s41531-024-00838-4

  
  

  QMRO: qmroHref
• Brolin KA, Schaeffer E, Kuri A et al. (2024). Environmental Risk Factors for Parkinson's Disease: A Critical Review and Policy Implications. nameOfConference

  
  

  DOI: 10.1002/mds.30067

  
  

  QMRO: qmroHref
• Mahlknecht P, Leiter S, Horlings C et al. (2024). Preferences regarding Disclosure of Risk for Parkinson's Disease in a Population‐based Study. nameOfConference

  
  

  DOI: 10.1002/mdc3.14264

  
  

  QMRO: qmroHref
• Azoidou V, Noyce AJ, Simonet C (2024). The effect of tactile cueing on dual task performance in Parkinson’s disease. A systematic review and meta-analysis. nameOfConference

  
  

  DOI: 10.1016/j.prdoa.2024.100284

  
  

  QMRO: qmroHref
• Step K, Eltaraifee E, Elsayed I et al. (2024). Advancing Parkinson's Disease Research in Africa: A Strategic Training Framework of the Global Parkinson's Genetics Program. nameOfConference

  
  

  DOI: 10.1002/mds.30051

  
  

  QMRO: qmroHref
• Lim S-Y, Tan AH, Ahmad-Annuar A et al. (2024). Uncovering the genetic basis of Parkinson's disease globally: from discoveries to the clinic. nameOfConference

  
  

  DOI: 10.1016/s1474-4422(24)00378-8

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/99549
• Schaeffer E, Yilmaz R, St. Louis EK et al. (2024). Ethical Considerations for Identifying Individuals in the Prodromal/Early Phase of Parkinson’s Disease: A Narrative Review. nameOfConference

  
  

  DOI: 10.3233/jpd-230428

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/99206
• Pereira GM, Teixeira-dos-Santos D, Soares NM et al. (publicationYear). A systematic review and meta-analysis of the prevalence of Parkinson’s disease in lower to upper-middle-income countries. nameOfConference

  
  

  DOI: 10.1038/s41531-024-00779-y

  
  

  QMRO: qmroHref
• Joerres C, Patyjewicz M, Cetin M et al. (2024). Assessing the prevalence of nitrous oxide usage in patients aged 35 years or under presenting with unprovoked VTE between 2021-2023. nameOfConference

  
  

  DOI: 10.1016/j.tru.2024.100184

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/99209
• Araújo R, Noyce AJ, Bloem BR (2024). Therapeutic ancillary examinations in clinical neurology. nameOfConference

  
  

  DOI: 10.1007/s00415-024-12663-z

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/99548
• Rudd KD, Lawler K, Callisaya ML et al. (2024). Hand Motor Dysfunction Is Associated with Both Subjective and Objective Cognitive Impairment across the Dementia Continuum.. nameOfConference

  
  

  DOI: 10.1159/000540412

  
  

  QMRO: qmroHref
• Francis M, Zirra A, Haque T et al. (2024). Rapid Voluntary Blinking as a Clinical Marker of Parkinson’s Disease. nameOfConference

  
  

  DOI: 10.3233/jpd-240005

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/99208
• Zhang Q, Noyce AJ, Robson J et al. (2024). No association between oral contraceptive exposure and subsequent MS: A population-based nested case–control study in primary care. nameOfConference

  
  

  DOI: 10.1177/13524585241258691

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/97520
• Zaloum SA, Paris A, Mair D et al. (2024). Evaluation of an ambulatory care pathway for patients with nitrous oxide-induced myeloneuropathy. nameOfConference

  
  

  DOI: 10.1136/bmjno-2024-000737

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/99205
• Li X, Gill A, Panzarasa P et al. (2024). Web Application to Enable Online Social Interactions in a Parkinson Disease Risk Cohort: Feasibility Study and Social Network Analysis. nameOfConference

  
  

  DOI: 10.2196/51977

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/95581
• Rees RN, Noyce AJ, Schrag AE (2024). Identification of Prodromal Parkinson Disease. nameOfConference

  
  

  DOI: 10.1212/wnl.0000000000209394

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/94797
• Patyjewicz M, Mair D, Zaloum SA et al. (2024). Recreational nitrous oxide and thrombotic events: a case series. nameOfConference

  
  

  DOI: 10.1136/bmjno-2023-000619

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/95129
• Badenoch JB, Paris A, Jacobs BM et al. (2024). Neuroanatomical and prognostic associations of depression in Parkinson’s disease. nameOfConference

  
  

  DOI: 10.1136/jnnp-2023-333007

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/97899
• Chang Y-H, Periñan MT, Wilson M et al. (publicationYear). AccessPD as a next generation registry to accelerate Parkinson’s disease research. nameOfConference

  
  

  DOI: 10.1038/s41531-024-00651-z

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/99202
• Simonet C, Pérez‐Carbonell L, Galmés‐Ordinas MA et al. (2024). The Motor Dysfunction Seen in Isolated REM Sleep Behavior Disorder. nameOfConference

  
  

  DOI: 10.1002/mds.29779

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/94884
• Ojo OO, Bandres‐Ciga S, Makarious MB et al. (2024). GBA1 rs3115534 Is Associated with REM Sleep Behavior Disorder in Parkinson's Disease in Nigerians. nameOfConference

  
  

  DOI: 10.1002/mds.29753

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/99203
• Lucas A, Noyce AJ, Gernez E et al. (2024). Nitrous oxide abuse direct measurement for diagnosis and follow-up: update on kinetics and impact on metabolic pathways. nameOfConference

  
  

  DOI: 10.1515/cclm-2023-1252

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/99201
• Reynoso A, Torricelli R, Jacobs BM et al. (2024). Gene–Environment Interactions for Parkinson's Disease. nameOfConference

  
  

  DOI: 10.1002/ana.26852

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/93869
• Kim JJ, Vitale D, Otani DV et al. (2024). Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease. nameOfConference

  
  

  DOI: 10.1038/s41588-023-01584-8

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/93868
• Gonzalez‐Robles C, Bartlett M, Burnell M et al. (2024). Embedding Patient Input in Outcome Measures for Long‐Term Disease‐Modifying Parkinson Disease Trials. nameOfConference

  
  

  DOI: 10.1002/mds.29691

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/93865
• Gernez E, Lucas A, Niguet J et al. (2024). What biological markers could be used for diagnosis and monitoring of nitrous oxide abuse?. nameOfConference

  
  

  DOI: 10.1111/ene.16188

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/93866
• Bramich S, Noyce AJ, King AE et al. (2024). Isolated rapid eye movement sleep behaviour disorder (iRBD) in the Island Study Linking Ageing and Neurodegenerative Disease (ISLAND) Sleep Study: protocol and baseline characteristics. nameOfConference

  
  

  DOI: 10.1111/jsr.14109

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/93863
• Toffoli M, Chohan H, Mullin S et al. (2023). Phenotypic effect of GBA1 variants in individuals with and without Parkinson's disease: The RAPSODI study. nameOfConference

  
  

  DOI: 10.1016/j.nbd.2023.106343

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/93864
• Mair D, Zaloum SA, Patel F et al. (2023). Effectiveness of interactive workshops to raise awareness of the neurological harms associated with nitrous oxide use: a cross-sectional study. nameOfConference

  
  

  DOI: 10.1016/s0140-6736(23)02119-0

  
  

  QMRO: qmroHref
• Bernard Healey SA, Giovannoni G, Noyce A et al. (2024). Impact of multiple sclerosis risk alleles on the plasma proteome. nameOfConference

  
  

  DOI: 10.1093/brain/awad363

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/91694
• Paris A, Mair D, Zaloum S et al. (2023). Nitrous oxide and its neurological harms. nameOfConference

  
  

  DOI: 10.1016/s1474-4422(23)00329-0

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/93925
• Gonzalez-Robles C, Weil RS, van Wamelen D et al. (2023). Outcome Measures for Disease-Modifying Trials in Parkinson’s Disease: Consensus Paper by the EJS ACT-PD Multi-Arm Multi-Stage Trial Initiative. nameOfConference

  
  

  DOI: 10.3233/jpd-230051

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/93859
• Jacobs BM, Tank P, Bestwick JP et al. (2024). Modifiable risk factors for multiple sclerosis have consistent directions of effect across diverse ethnic backgrounds: a nested case–control study in an English population-based cohort. nameOfConference

  
  

  DOI: 10.1007/s00415-023-11971-0

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/90685
• Wang X, St George RJ, Bindoff AD et al. (2024). Estimating presymptomatic episodic memory impairment using simple hand movement tests: A cross‐sectional study of a large sample of older adults. nameOfConference

  
  

  DOI: 10.1002/alz.13401

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/89342
• Simonet C, Mahlknecht P, Marini K et al. (2023). The Emergence and Progression of Motor Dysfunction in Individuals at Risk of Parkinson's Disease. nameOfConference

  
  

  DOI: 10.1002/mds.29496

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/89068
• Noyce A (2023). Nitrous oxide-induced myeloneuropathy: a case series. nameOfConference

  
  

  DOI: 10.1136/jnnp-2023-331131

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/85705
• Leonard HL, Murtadha R, Martinez-Carrasco A et al. (publicationYear). Author Correction: The IPDGC/GP2 Hackathon - an open science event for training in data science, genomics, and collaboration using Parkinson’s disease data. nameOfConference

  
  

  DOI: 10.1038/s41531-023-00529-6

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/93861
• Jacobs BM, Schalk L, Dunne A et al. (2023). ADAMS project: a genetic Association study in individuals from Diverse Ancestral backgrounds with Multiple Sclerosis based in the UK. nameOfConference

  
  

  DOI: 10.1136/bmjopen-2023-071656

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/88025
• Senkevich K, Alipour P, Chernyavskaya E et al. (2023). Potential Protective Link Between Type I Diabetes and Parkinson's Disease Risk and Progression. nameOfConference

  
  

  DOI: 10.1002/mds.29424

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/93862
• Pérez‐Carbonell L, Simonet C, Chohan H et al. (2023). The Views of Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder on Risk Disclosure. nameOfConference

  
  

  DOI: 10.1002/mds.29403

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/93867
• Alvarez Jerez P, Alcantud JL, de los Reyes-Ramírez L et al. (publicationYear). Exploring the genetic and genomic connection underlying neurodegeneration with brain iron accumulation and the risk for Parkinson’s disease. nameOfConference

  
  

  DOI: 10.1038/s41531-023-00496-y

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/93858
• Leonard HL, Murtadha R, Martinez-Carrasco A et al. (publicationYear). The IPDGC/GP2 Hackathon - an open science event for training in data science, genomics, and collaboration using Parkinson’s disease data. nameOfConference

  
  

  DOI: 10.1038/s41531-023-00472-6

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/85208
• Foltynie T, Gandhi S, Gonzalez-Robles C et al. (2023). Towards a multi-arm multi-stage platform trial of disease modifying approaches in Parkinson’s disease. nameOfConference

  
  

  DOI: 10.1093/brain/awad063

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/85210
• Paris A, Lake L, Joseph A et al. (2023). Nitrous oxide-induced subacute combined degeneration of the cord: diagnosis and treatment. nameOfConference

  
  

  DOI: 10.1136/pn-2022-003631

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/85209
• Nagy AV, Leschziner G, Eriksson SH et al. (2023). Cognitive impairment in REM-sleep behaviour disorder and individuals at risk of Parkinson's disease. nameOfConference

  
  

  DOI: 10.1016/j.parkreldis.2023.105312

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/85211
• Frisoni GB, Altomare D, Ribaldi F et al. (2023). Dementia prevention in memory clinics: recommendations from the European task force for brain health services. nameOfConference

  
  

  DOI: 10.1016/j.lanepe.2022.100576

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/84311
• Noyce A (2022). The association between anti-epileptic drugs and incident Parkinson’s disease in UK Biobank. nameOfConference

  
  

  DOI: 10.1001/jamaneurol.2022.4699

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/82500
• Bramich S, Verdi K, Salmon K et al. (2023). REM sleep behaviour disorder: the importance of early identification in primary care. nameOfConference

  
  

  DOI: 10.3399/bjgp23x731721

  
  

  QMRO: qmroHref
• Dadu A, Satone V, Kaur R et al. (publicationYear). Identification and prediction of Parkinson’s disease subtypes and progression using machine learning in two cohorts. nameOfConference

  
  

  DOI: 10.1038/s41531-022-00439-z

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/84118
• Krohn L, Heilbron K, Blauwendraat C et al. (publicationYear). Genome-wide association study of REM sleep behavior disorder identifies polygenic risk and brain expression effects. nameOfConference

  
  

  DOI: 10.1038/s41467-022-34732-5

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/83085
• Zirra A, Rao SC, Bestwick J et al. (2023). Gender Differences in the Prevalence of Parkinson's Disease. nameOfConference

  
  

  DOI: 10.1002/mdc3.13584

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/82482
• Periñán MT, Brolin K, Bandres‐Ciga S et al. (2022). Effect Modification between Genes and Environment and Parkinson's Disease Risk. nameOfConference

  
  

  DOI: 10.1002/ana.26467

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/80493
• Jacobs BM, Peter M, Giovannoni G et al. (2022). Towards a global view of multiple sclerosis genetics. nameOfConference

  
  

  DOI: 10.1038/s41582-022-00704-y

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/80522
• Kent DM, Leung LY, Puttock EJ et al. (2022). Development of Parkinson Disease and Its Relationship with Incidentally Discovered White Matter Disease and Covert Brain Infarction in a Real‐World Cohort. nameOfConference

  
  

  DOI: 10.1002/ana.26458

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/80538
• Schumacher‐Schuh AF, Bieger A, Okunoye O et al. (2022). Underrepresented Populations in Parkinson's Genetics Research: Current Landscape and Future Directions. nameOfConference

  
  

  DOI: 10.1002/mds.29126

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/78952
• Day JO, Smith S, Noyce AJ et al. (2022). Challenges of Incorporating Digital Health Technology Outcomes in a Clinical Trial: Experiences from PD STAT. nameOfConference

  
  

  DOI: 10.3233/jpd-223162

  
  

  QMRO: qmroHref
• Bramich S, King A, Kuruvilla M et al. (2022). Isolated REM sleep behaviour disorder: current diagnostic procedures and emerging new technologies. nameOfConference

  
  

  DOI: 10.1007/s00415-022-11213-9

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/78951
• Liu H, Dehestani M, Blauwendraat C et al. (2022). Polygenic Resilience Modulates the Penetrance of Parkinson Disease Genetic Risk Factors. nameOfConference

  
  

  DOI: 10.1002/ana.26416

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/79159
• Foote IF, Jacobs BM, Mathlin G et al. (2022). The shared genetic architecture of modifiable risk for Alzheimer's disease: a genomic structural equation modelling study. nameOfConference

  
  

  DOI: 10.1016/j.neurobiolaging.2022.02.016

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/79699
• Hone L, Jacobs BM, Marshall C et al. (2022). Age-specific effects of childhood body mass index on multiple sclerosis risk. nameOfConference

  
  

  DOI: 10.1007/s00415-022-11161-4

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/86260
• Simonet C, Bestwick J, Jitlal M et al. (2022). Assessment of Risk Factors and Early Presentations of Parkinson Disease in Primary Care in a Diverse UK Population. nameOfConference

  
  

  DOI: 10.1001/jamaneurol.2022.0003

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/77358
• Marshall CR, Noyce AJ, Neligan A et al. (2022). Brain health: The hidden casualty of a humanitarian crisis. nameOfConference

  
  

  DOI: 10.1016/j.lanepe.2022.100374

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/77761
• Noyce A (2022). No evidence for association between polygenic risk of Multiple Sclerosis and MRI phenotypes in ~30,000 healthy adult UK Biobank participants. nameOfConference

  
  

  DOI: 10.1177/2F13524585221075744

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/76333
• Noyce A (2022). Assessment of Risk Factors and Early Presentations of Parkinson Disease in Primary Care in a Diverse UK Population. nameOfConference

  
  

  DOI: 10.1001/jamaneurol.2022.0003

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/75666
• Cornejo‐Olivas M, Wu L, Noyce A (2022). Disruption of Mitochondrial Complex I Induces Progressive Parkinsonism. nameOfConference

  
  

  DOI: 10.1002/mds.28961

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/77460
• Bothongo PLK, Jitlal M, Parry E et al. (2022). Dementia risk in a diverse population: A single-region nested case-control study in the East End of London. nameOfConference

  
  

  DOI: 10.1016/j.lanepe.2022.100321

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/75791
• Noyce A (2022). Surveying global availability of Parkinson’s disease treatment. nameOfConference

  
  

  DOI: 10.3233/JPD-213006

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/76599
• Noyce A (2022). The potential utility of smell testing to screen for neurodegenerative disorders. nameOfConference

  
  

  DOI: 10.1080/14737159.2022.2037424

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/76598
• Dobson R, Marshall C, Noyce A (2022). Social determinants of neurological disease: tackling inequalities. nameOfConference

  
  

  DOI: 10.1016/s1474-4422(22)00005-9

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/76489
• Noyce A (2022). Developing and Assessing a New Web-based Tapping Test for Measuring Distal Movement in Parkinson’s Disease: a Distal Finger Tapping Test. nameOfConference

  
  

  DOI: 10.1038/s41598-021-03563-7

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/75667
• Mitchell E, Chohan H, Bestwick JP et al. (2022). Alcohol and Parkinson’s Disease: A Systematic Review and Meta-Analysis. nameOfConference

  
  

  DOI: 10.3233/jpd-223522

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/84117
• Chohan H, Simonet C, Gill A et al. (2022). What, when and how should the information on iRBD and risk of Parkinson's disease and related conditions be communicated?. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Storm CS, Kia DA, Almramhi MM et al. (publicationYear). Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome. nameOfConference

  
  

  DOI: 10.1038/s41467-021-26280-1

  
  

  QMRO: qmroHref
• Bestwick JP, Auger SD, Simonet C et al. (2021). Improving estimation of Parkinson’s disease risk—the enhanced PREDICT-PD algorithm. nameOfConference

  
  

  DOI: 10.1038/s41531-021-00176-9

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/68734
• Huxford B, Haque T, Joseph AB et al. (2022). Parkinson's Disease and Type 2 Diabetes: HbA1c Is Associated with Motor and Cognitive Severity. nameOfConference

  
  

  DOI: 10.1002/mds.28829

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/74651
• Heilbron K, Jensen MP, Bandres-Ciga S et al. (2021). Unhealthy Behaviours and Risk of Parkinson’s Disease: A Mendelian Randomisation Study. nameOfConference

  
  

  DOI: 10.3233/jpd-202487

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/73518
• Bestwick J, Auger S, Schrag A et al. (2021). Optimising classification of Parkinson’s disease based on motor, olfactory, neuropsychiatric and sleep features. nameOfConference

  
  

  DOI: 10.1038/s41531-021-00226-2

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/73808
• Hone L, Jacobs BM, Marshall C et al. (publicationYear). Age-specific effects of childhood Body Mass Index on multiple sclerosis risk. nameOfConference

  
  

  DOI: 10.1101/2021.09.12.21263445

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/78265
• Noyce A, Beccano-Kelly D, Bandres-Ciga S et al. (2021). Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunities. nameOfConference

  
  

  DOI: 10.36866/123.32

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/74653
• Simonet C, Noyce AJ (2021). Domotics, Smart Homes, and Parkinson’s Disease. nameOfConference

  
  

  DOI: 10.3233/jpd-202398

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/70669
• Simonet C, Noyce A (publicationYear). Mild parkinsonian signs: the interface between aging and Parkinson’s disease. nameOfConference

  
  

  DOI: 10.47795/khgp5988

  
  

  QMRO: qmroHref
• Gialluisi A, Reccia MG, Modugno N et al. (2021). Identification of sixteen novel candidate genes for late onset Parkinson’s disease. nameOfConference

  
  

  DOI: 10.1186/s13024-021-00455-2

  
  

  QMRO: qmroHref
• Jacobs BM, Noyce AJ, Bestwick J et al. (2021). Gene-Environment Interactions in Multiple Sclerosis: A UK Biobank Study. nameOfConference

  
  

  DOI: 10.1212/nxi.0000000000001007

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/70963
• Blauwendraat C, Iwaki H, Makarious MB et al. (2021). Investigation of Autosomal Genetic Sex Differences in Parkinson's Disease. nameOfConference

  
  

  DOI: 10.1002/ana.26090

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/71700
• Estiar MA, Senkevich K, Yu E et al. (2021). Lack of Causal Effects or Genetic Correlation between Restless Legs Syndrome and Parkinson's Disease. nameOfConference

  
  

  DOI: 10.1002/mds.28640

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/71705
• Bandres-Ciga S, Saez-Atienzar S, Kim JJ et al. (2021). Correction to: Large‑scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease. nameOfConference

  
  

  DOI: 10.1007/s00401-021-02309-z

  
  

  QMRO: qmroHref
• Ismail AS, Goodwin GR, Castrejon-Pita JR et al. (2021). A novel capsule-based smell test fabricated via coaxial dripping. nameOfConference

  
  

  DOI: 10.1098/rsif.2021.0039

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/71695
• Chen Z, Zhang D, Reynolds RH et al. (publicationYear). Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage. nameOfConference

  
  

  DOI: 10.1038/s41467-021-22262-5

  
  

  QMRO: qmroHref
• Bestwick JP, Auger SD, Simonet C et al. (publicationYear). Improving estimation of Parkinson’s disease risk—the enhanced PREDICT-PD algorithm. nameOfConference

  
  

  DOI: 10.1038/s41531-021-00176-9

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/71965
• Jitlal M, Amirthalingam G, Karania T et al. (publicationYear). The influence of socioeconomic deprivation on dementia mortality, age at death and quality of diagnosis: a nationwide death records study in England and Wales 2001-2017. nameOfConference

  
  

  DOI: 10.3233/JAD-210089

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/70919
• Chohan H, Senkevich K, Patel RK et al. (2021). Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression. nameOfConference

  
  

  DOI: 10.1002/mds.28551

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/70848
• Foote IF, Jacobs BM, Mathlin G et al. (publicationYear). The Genetic Architecture of Alzheimer’s Disease Risk: A Genomic Structural Equation Modelling Study. nameOfConference

  
  

  DOI: 10.1101/2021.02.23.21252211

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/72648
• Jensen MP, Jacobs BM, Dobson R et al. (2021). Lower Lymphocyte Count is Associated With Increased Risk of Parkinson's Disease. nameOfConference

  
  

  DOI: 10.1002/ana.26034

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/70059
• Kang X, Ploner A, Pedersen N et al. (2021). Tumor Necrosis Factor Inhibition and Parkinson Disease: A Mendelian Randomization Study. nameOfConference

  
  

  DOI: 10.1212/WNL.0000000000011630

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/69397
• Noyce A (2021). Infection and Risk of Parkinson’s disease. nameOfConference

  
  

  DOI: 10.3233/JPD-202279

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/68810
• Program TGPG (2021). GP2: The Global Parkinson's Genetics Program. nameOfConference

  
  

  DOI: 10.1002/mds.28494

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/70356
• Hone L, Jacobs B, Noyce A et al. (2021). Age-specific effects of childhood BMI on multiple sclerosis risk: a Mendelian Randomisation study. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/75629
• Senkevich K, Bandres-Ciga S, Yu E et al. (2021). No Evidence for a Causal Relationship Between Cancers and Parkinson's Disease.. nameOfConference

  
  

  DOI: 10.3233/jpd-202474

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/70670
• Simonet C, Galmes MA, Lambert C et al. (2021). Slow Motion Analysis of Repetitive Tapping (SMART) Test: Measuring Bradykinesia in Recently Diagnosed Parkinson’s Disease and Idiopathic Anosmia. nameOfConference

  
  

  DOI: 10.3233/jpd-212683

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/72405
• Blauwendraat C, Makarious MB, Leonard HL et al. (publicationYear). A population scale analysis of rare SNCA variation in the UK Biobank. nameOfConference

  
  

  DOI: 10.1016/j.nbd.2020.105182

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/68806
• Jacobs BM, Smets I, Giovannoni G et al. (2021). Regarding: Nicotinic acetylcholine receptors α7 and α9 modify tobacco smoke risk for multiple sclerosis. nameOfConference

  
  

  DOI: 10.1177/1352458520969941

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/69385
• Foote IF, Jacobs BM, Noyce AJ et al. (2020). Exploring the shared genetic architecture of modifiable risk factors and related endophenotypes of Alzheimer’s disease: A genomic SEM study. nameOfConference

  
  

  DOI: 10.1002/alz.045164

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/70959
• Noyce AJ, Klein C (2021). Genetic Risk of Alzheimer's Disease – Sleepless with the Enemy. nameOfConference

  
  

  DOI: 10.1002/ana.25938

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/68509
• Iwaki H, Blauwendraat C, Leonard HL et al. (2020). Differences in the Presentation and Progression of Parkinson's Disease by Sex. nameOfConference

  
  

  DOI: 10.1002/mds.28312

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/68641
• Auger SD, Jacobs BM, Dobson R et al. (2020). Big data, machine learning and artificial intelligence: a neurologist’s guide. nameOfConference

  
  

  DOI: 10.1136/practneurol-2020-002688

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/67605
• Auger S, Jacobs B, Dobson R et al. (2020). Navigating a world of big data, machine learning and artificial intelligence: a neurologist's guide. nameOfConference

  
  

  DOI: 10.1136/practneurol-2020-002688

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/67242
• Jacobs B, Belete D, Bestwick J et al. (2020). Parkinson’s disease determinants, prediction and gene-environment interactions in the UK Biobank. nameOfConference

  
  

  DOI: 10.1136/jnnp-2020-323646

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/66809
• Cheong J, Goh Z, Marras C et al. (2020). The impact of COVID-19 on access to Parkinson’s disease medication. nameOfConference

  
  

  DOI: 10.1002/mds.28293

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/66849
• Noyce A (publicationYear). Evaluating lipid-lowering drug targets for Parkinson’s disease prevention with Mendelian randomization. nameOfConference

  
  

  DOI: 10.1002/ana.25880

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/66846
• Mencacci NE, Reynolds R, Ruiz SG et al. (2020). Dystonia genes functionally converge in specific neurons and share neurobiology with psychiatric disorders. nameOfConference

  
  

  DOI: 10.1093/brain/awaa217

  
  

  QMRO: qmroHref
• Jacobs B, Taylor T, Awad A et al. (2020). Summary-data-based mendelian randomisation prioritises potential druggable targets for Multiple Sclerosis. nameOfConference

  
  

  DOI: 10.1093/braincomms/fcaa119

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/65644
• Akram N, Li H, Ben-Joseph A et al. (publicationYear). Developing and Validating a New Web-Based Tapping Test for Measuring Distal Bradykinesia in Parkinson’s Disease. nameOfConference

  
  

  DOI: 10.1101/2020.06.30.20141572

  
  

  QMRO: qmroHref
• Noyce A (2020). Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease. nameOfConference

  
  

  DOI: 10.1007/s00401-020-02181-3

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/65756
• Marini K, Mahlknecht P, Tutzer F et al. (publicationYear). Application of a Simple Parkinson's Disease Risk Score in a Longitudinal Population‐Based Cohort. nameOfConference

  
  

  DOI: 10.1002/mds.28127

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/65120
• Williams DM, Bandres-Ciga S, Heilbron K et al. (publicationYear). Evaluating lipid-lowering drug targets for Parkinson disease prevention with Mendelian randomization. nameOfConference

  
  

  DOI: 10.1101/2020.05.04.20090142

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/68718
• Cheong J, de Pablo-Fernandez E, Foltynie T et al. (publicationYear). The association between type 2 diabetes mellitus and Parkinson’s disease. nameOfConference

  
  

  DOI: 10.3233/JPD-191900

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/64717
• Iwaki H, Blauwendraat C, Leonard HL et al. (publicationYear). Differences in the presentation and progression of Parkinson’s disease by sex. nameOfConference

  
  

  DOI: 10.1101/2020.04.08.20058370

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/68702
• Bestwick JP, Auger SD, Simonet C et al. (publicationYear). Improving estimation of Parkinson’s disease risk - The enhanced PREDICT-PD algorithm. nameOfConference

  
  

  DOI: 10.1101/2020.03.16.20037002

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/68733
• Auger S, Noyce A (publicationYear). Testing shortened versions of smell tests to screen for hyposmia in Parkinson’s disease. nameOfConference

  
  

  DOI: 10.1002/mdc3.12928

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/63158
• Guelfi S, D’Sa K, Botía JA et al. (publicationYear). Regulatory sites for splicing in human basal ganglia are enriched for disease-relevant information. nameOfConference

  
  

  DOI: 10.1038/s41467-020-14483-x

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/66523
• (2020). Corrigendum. nameOfConference

  
  

  DOI: 10.1093/brain/awaa036

  
  

  QMRO: qmroHref
• Dobson R, Jitlal M, Marshall CR et al. (2020). Ethnic and Socioeconomic Associations with Multiple Sclerosis Risk. nameOfConference

  
  

  DOI: 10.1002/ana.25688

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/62858
• Dobson R, Noyce A, Giovannoni G et al. (2020). BMI and low serum vitamin D are causal risk factors for Multiple Sclerosis: a Mendelian Randomisation study. nameOfConference

  
  

  DOI: 10.1212/NXI.0000000000000662

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/62737
• Alarcón F, Maldonado J-C, Cañizares M et al. (2020). Motor Dysfunction as a Prodrome of Parkinson’s Disease. nameOfConference

  
  

  DOI: 10.3233/jpd-191851

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/66256
• Noyce A, Giovannoni G, Scheltens P et al. (2020). Time matters in brain health: how should society prepare for a growing population at risk of neurodegenerative diseases?. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Noyce A, Ben-Joseph A, MARSHALL C et al. (publicationYear). Ethnic variation in the manifestation of Parkinson’s disease: a narrative review. nameOfConference

  
  

  DOI: 10.3233/JPD-191763

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/62340
• Simonet C, Schrag A, Lees AJ et al. (2021). The motor prodromes of parkinson’s disease: from bedside observation to large-scale application. nameOfConference

  
  

  DOI: 10.1007/s00415-019-09642-0

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/67647
• Nalls MA, Blauwendraat C, Vallerga CL et al. (2019). Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies. nameOfConference

  
  

  DOI: 10.1016/s1474-4422(19)30320-5

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/62389
• Noyce A, International Parkinson’s Disease Genomics Consortium (IPDGC) (2020). Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia. nameOfConference

  
  

  DOI: 10.1093/brain/awz350

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/62988
• Bandres‐Ciga S, Ahmed S, Sabir MS et al. (2019). The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population‐Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight. nameOfConference

  
  

  DOI: 10.1002/mds.27864

  
  

  QMRO: qmroHref
• Noyce AJ, Bandres‐Ciga S, Kim J et al. (2019). The Parkinson's Disease Mendelian Randomization Research Portal. nameOfConference

  
  

  DOI: 10.1002/mds.27873

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/60502
• Bandres-Ciga S, Noyce A, Traynor BJ (publicationYear). Mendelian randomization: a journey from obscurity to center stage with a few potholes along the way. nameOfConference

  
  

  DOI: 10.1001/jamaneurol.2019.3419

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/62387
• Noyce A, Iwaki H (2019). Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts. nameOfConference

  
  

  DOI: 10.1002/mds.27845

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/60007
• Neligan A, Noyce AJ, Gosavi TD et al. (2019). Change in Mortality of Generalized Convulsive Status Epilepticus in High-Income Countries Over Time. nameOfConference

  
  

  DOI: 10.1001/jamaneurol.2019.1268

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/59581
• Iwaki H, Blauwendraat C, Leonard HL et al. (2019). Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts. nameOfConference

  
  

  DOI: 10.1212/nxg.0000000000000348

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/59505
• Hasan H, Burrows M, Athauda DS et al. (2019). The BRadykinesia Akinesia INcoordination (BRAIN) Tap Test: Capturing the Sequence Effect. nameOfConference

  
  

  DOI: 10.1002/mdc3.12798

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/58738
• Fernández‐Santiago R, Martín‐Flores N, Antonelli F et al. (2019). SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease. nameOfConference

  
  

  DOI: 10.1002/mds.27770

  
  

  QMRO: qmroHref
• NOYCE AJ, Neligan A, Gosavi T et al. (2019). Change in Mortality of Generalized Convulsive Status Epilepticus in High-Income Countries Over Time A Systematic Review and Meta-analysis. nameOfConference

  
  

  DOI: 10.1001/jamaneurol.2019.1268

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/58383
• Billingsley KJ, Barbosa IA, Bandrés-Ciga S et al. (publicationYear). Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset. nameOfConference

  
  

  DOI: 10.1038/s41531-019-0080-x

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/69502
• Joseph T, Auger SD, Peress L et al. (2019). Screening performance of abbreviated versions of the UPSIT smell test. nameOfConference

  
  

  DOI: 10.1007/s00415-019-09340-x

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/57823
• Reynolds RH, Botía J, Nalls MA et al. (publicationYear). Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability. nameOfConference

  
  

  DOI: 10.1038/s41531-019-0076-6

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/69262
• NOYCE AJ, International Parkinson's Disease Genomics Consortium (IPDGC) (2019). Parkinson's disease age at onset genome-wide association study: Defining heritability, genetic loci, and α-synuclein mechanisms.. nameOfConference

  
  

  DOI: 10.1002/mds.27659

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/57077
• Heilbron K, NOYCE AJ, Fontanillas P et al. (2019). The Parkinson’s Phenome—Traits Associated with Parkinson's Disease in a Broadly Phenotyped Cohort. nameOfConference

  
  

  DOI: 10.1038/s41531-019-0077-5

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/57234
• Schrag A, Anastasiou Z, Ambler G et al. (publicationYear). Predicting Diagnosis of Parkinson’s disease: A Risk Algorithm based on Primary Care presentations. nameOfConference

  
  

  DOI: 10.1002/mds.27616

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/55648
• NOYCE AJ (2019). Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis. nameOfConference

  
  

  DOI: 10.1002/ana.25431

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/55486
• Bandres‐Ciga S, Saez‐Atienzar S, Bonet‐Ponce L et al. (2019). The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease. nameOfConference

  
  

  DOI: 10.1002/mds.27614

  
  

  QMRO: qmroHref
• NOYCE AJ, Rees R, Schrag A (2018). The prodromes of Parkinson's disease.. nameOfConference

  
  

  DOI: 10.1111/ejn.14269

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/55013
• Kia DA, Sabir MS, Ahmed S et al. (2018). LRP10 in α-synucleinopathies. nameOfConference

  
  

  DOI: 10.1016/s1474-4422(18)30401-0

  
  

  QMRO: qmroHref
• Acharya A, Basnett I, Gutteridge C et al. (2018). Laughter isn't always the best medicine.. nameOfConference

  
  

  DOI: 10.1136/bmj.k4579

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/56011
• Blauwendraat C, Reed X, Kia DA et al. (2018). Frequency of Loss of Function Variants in LRRK2 in Parkinson Disease. nameOfConference

  
  

  DOI: 10.1001/jamaneurol.2018.1885

  
  

  QMRO: qmroHref
• Rees RN, Acharya AP, Schrag A et al. (2018). An early diagnosis is not the same as a timely diagnosis of Parkinson's disease. nameOfConference

  
  

  DOI: 10.12688/f1000research.14528.1

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/55014
• NOYCE AJ (2018). Mendelian randomization study shows no causal relationship between circulating urate levels and Parkinson’s disease.. nameOfConference

  
  

  DOI: 10.1002/ana.25294

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/42225
• De Pablo-Fernandez E, Goldacre R, Pakpoor J et al. (2018). Association between diabetes and subsequent Parkinson disease. nameOfConference

  
  

  DOI: 10.1212/wnl.0000000000005771

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/36482
• Noyce A (2018). Remembering the man behind An Essay on the Shaking Palsy. nameOfConference

  
  

  DOI: 10.1016/s1474-4422(17)30467-2

  
  

  QMRO: qmroHref
• Keddie S, Adams A, Kelso ARC et al. (2018). No laughing matter: subacute degeneration of the spinal cord due to nitrous oxide inhalation. nameOfConference

  
  

  DOI: 10.1007/s00415-018-8801-3

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/35883
• Weil RS, Schwarzkopf DS, Bahrami B et al. (2018). Assessing cognitive dysfunction in Parkinson's disease: An online tool to detect visuo‐perceptual deficits. nameOfConference

  
  

  DOI: 10.1002/mds.27311

  
  

  QMRO: qmroHref
• NOYCE AJ (2018). Assessing cognitive dysfunction in Parkinson’s: An online tool to detect visuo-perceptual deficits. nameOfConference

  
  

  DOI: 10.1002/mds.27311

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/36724
• Noyce AJ, Dickson J, Rees RN et al. (2018). Dopamine reuptake transporter–single‐photon emission computed tomography and transcranial sonography as imaging markers of prediagnostic Parkinson's disease. nameOfConference

  
  

  DOI: 10.1002/mds.27282

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/32124
• Blauwendraat C, Kia DA, Pihlstrøm L et al. (2018). Insufficient evidence for pathogenicity of SNCA His50Gln (H50Q) in Parkinson's disease. nameOfConference

  
  

  DOI: 10.1016/j.neurobiolaging.2017.12.012

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/56452
• Shribman S, Noyce A, Gnanapavan S et al. (2018). Cryptococcal meningitis in apparently immunocompetent patients: association with idiopathic CD4+ lymphopenia. nameOfConference

  
  

  DOI: 10.1136/practneurol-2017-001800

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/32063
• Shribman S, Hasan H, Hadavi S et al. (2018). The BRAIN test: a keyboard-tapping test to assess disability and clinical features of multiple sclerosis. nameOfConference

  
  

  DOI: 10.1007/s00415-017-8690-x

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/32346
• Noyce AJ, Lees A (2017). Observations on a 2-Step Approach to Screening for Parkinson Disease. nameOfConference

  
  

  DOI: 10.1001/jamaneurol.2017.3202

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/36338
• Noyce A, Bandopadhyay R (2017). Parkinson's Disease: Basic Pathomechanisms and a Clinical Overview.. nameOfConference

  
  

  DOI: 10.1007/978-3-319-57193-5_3

  
  

  QMRO: qmroHref
• Raciborska DD, Noyce AJ, Pyne D et al. (publicationYear). Lupus myelopathy. nameOfConference

  
  

  DOI: 10.1136/practneurol-2017-001756

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/31205
• Lynch DS, Loh SHY, Harley J et al. (2017). Nonsyndromic Parkinson disease in a family with autosomal dominant optic atrophy due to OPA1 mutations. nameOfConference

  
  

  DOI: 10.1212/NXG.0000000000000188

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/32250
• Noyce AJ, Kia DA, Hemani G et al. (2017). Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study. nameOfConference

  
  

  DOI: 10.1371/journal.pmed.1002314

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/29543
• Noyce A, Kia D, Hemani G et al. (2017). Increased BMI May Protect against Parkinson's Disease: Evidence From Mendelian Randomisation Study. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/29523
• Magdalinou NK, Noyce AJ, Pinto R et al. (2017). Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomics. nameOfConference

  
  

  DOI: 10.1016/j.parkreldis.2017.01.016

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/29063
• Pakpoor J, Noyce A, Goldacre R et al. (2017). Viral hepatitis and Parkinson disease. nameOfConference

  
  

  DOI: 10.1212/wnl.0000000000003848

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/32354
• Noyce AJ, Schrag A, Masters JM et al. (2017). Subtle motor disturbances in PREDICT-PD participants.. nameOfConference

  
  

  DOI: 10.1136/jnnp-2016-314524

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/29663
• Hasan H, Athauda DS, Foltynie T et al. (2017). Technologies Assessing Limb Bradykinesia in Parkinson’s Disease. nameOfConference

  
  

  DOI: 10.3233/JPD-160878

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/32337
• Noyce AJ, R'Bibo L, Peress L et al. (2017). PREDICT-PD: An online approach to prospectively identify risk indicators of Parkinson's disease.. nameOfConference

  
  

  DOI: 10.1002/mds.26898

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/29563
• Noyce A, Dickson J, Bestwick J et al. (2017). Associations of DAT SPECT and TCS with prodromal features of Parkinson's disease: Results in PREDICT-PD participants. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Nagy A, Hardaker E, Bestwick J et al. (2017). Cognition in the PREDICT-PD Cohort. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Lubbe SJ, Escott-Price V, Gibbs JR et al. (publicationYear). Additional rare variant analysis in Parkinson’s disease cases with and without known pathogenic mutations: evidence for oligogenic inheritance. nameOfConference

  
  

  DOI: 10.1093/hmg/ddw348

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/31143
• Adams-Carr KL, Bestwick JP, Shribman S et al. (2016). Constipation preceding Parkinson's disease: a systematic review and meta-analysis.. nameOfConference

  
  

  DOI: 10.1136/jnnp-2015-311680

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/49431
• Hasan H, Athauda DS, Foltynie T et al. (2016). Objective decrement in Parkinson's disease - A new parameter for the BRAIN tap test. 20th International Congress of Parkinson's Disease and Movement Disorders

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Salat D, Noyce AJ, Schrag A et al. (2016). Challenges of modifying disease progression in prediagnostic Parkinson's disease. nameOfConference

  
  

  DOI: 10.1016/S1474-4422(16)00060-0

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/32049
• Mok KY, Sheerin U, Simón-Sánchez J et al. (2016). Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data. nameOfConference

  
  

  DOI: 10.1016/S1474-4422(16)00071-5

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/31024
• Noyce AJ, Lees AJ, Schrag A-E (2016). The prediagnostic phase of Parkinson's disease. nameOfConference

  
  

  DOI: 10.1136/jnnp-2015-311890

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/32347
• Masters JM, Noyce AJ, Lynham S et al. (2016). A comprehensive characterisation of the salivary proteome of patients with Parkinson's disease. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Noyce AJ, Schrag A, Masters J et al. (2016). Blinded video assessment of subtle Parkinsonian signs in PREDICT-PD participants. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Mok KY, Sheerin U, Simon-Sanchez J et al. (2016). Deletions at 22q11.2 in idiopathic Parkinson's disease: A combined analysis of GWAS data. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• R'Bibo L, Mencacci NE, Schrag A et al. (2016). Exploring association of GBA variants with pre-diagnostic features of PD in the PREDICT-PD cohort: A nested case-control study. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Simonet C, Noyce AJ, Ling H et al. (2016). Handwriting in Parkinson's disease: Systematic review and preliminary study. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Osborne CW, Bestwick J, Giovannoni G et al. (2016). Participant feedback in the PREDICT-PD study. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Noyce AJ, Nalls MA (2016). Mendelian Randomization — the Key to Understanding Aspects of Parkinson's Disease Causation?. nameOfConference

  
  

  DOI: 10.1002/mds.26492

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/31083
• Noyce A, Bestwick J, Mencacci N et al. (2015). PREDICT-PD: Identifying Risk of Parkinson's disease in the Community. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Masters JM, Bestwick J, Warner TT et al. (2015). Systematic review and meta‐analysis of salivary protein concentration in Parkinson's disease. nameOfConference

  
  

  DOI: 10.1002/mds.26462

  
  

  QMRO: qmroHref
• Adams-Carr K, Schrag A, Shribman S et al. (2015). CONSTIPATION PRECEDING PARKINSON'S DISEASE–META-ANALYSIS. nameOfConference

  
  

  DOI: 10.1136/jnnp-2015-312379.98

  
  

  QMRO: qmroHref
• Masters J, Noyce A, Giovannoni G et al. (2015). ELEVATED SALIVARY DJ-1 IN PARKINSON'S DISEASE IS ASSOCIATED WITH ALTERED SALIVARY SECRETION. nameOfConference

  
  

  DOI: 10.1136/jnnp-2015-312379.23

  
  

  QMRO: qmroHref
• Nalls MA, McLean CY, Rick J et al. (2015). Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study. nameOfConference

  
  

  DOI: 10.1016/s1474-4422(15)00178-7

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/31923
• Masters JM, Noyce AJ, Warner TT et al. (2015). Elevated salivary protein in Parkinson's disease and salivary DJ-1 as a potential marker of disease severity. nameOfConference

  
  

  DOI: 10.1016/j.parkreldis.2015.07.021

  
  

  QMRO: qmroHref
• Noyce AJ, Mencacci NE, Schrag A et al. (2015). Web‐based assessment of Parkinson's prodromal markers identifies GBA variants. nameOfConference

  
  

  DOI: 10.1002/mds.26249

  
  

  QMRO: qmroHref
• Nagy A, Noyce A, Velayos-Baeza A et al. (2015). Late Emergence of Parkinsonian Phenotype and Abnormal Dopamine Transporter Scan in Chorea‐Acanthocytosis. nameOfConference

  
  

  DOI: 10.1002/mdc3.12138

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/31025
• Adams-Carr KL, Schrag A, Shribman S et al. (2015). Constipation preceding Parkinson's disease - Systematic review and meta-analysis. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Masters JM, Noyce AJ, Giovannoni G et al. (2015). Elevated salivary DJ-1 in Parkinson's disease is associated with altered salivary secretion. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Athauda DS, Hasan H, Noyce A et al. (2015). Evaluating the use of the online bradykinesia-akinesia Incoordination (BRAIN) test in Parkinson's disease in "on" and "off" states. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Magdalinou N, Ling H, Noyce A et al. (2015). The visual estimation of midbrain to pons ratio combined with cerebrospinal fluid biomarkers improves the diagnostic accuracy of PSP. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Schrag A, Horsfall L, Walters K et al. (2015). Prediagnostic presentations of Parkinson's disease in primary care: a case-control study. nameOfConference

  
  

  DOI: 10.1016/s1474-4422(14)70287-x

  
  

  QMRO: qmroHref
• Torsney KM, Noyce AJ, Doherty KM et al. (2014). Bone health in Parkinson's disease: a systematic review and meta-analysis.. nameOfConference

  
  

  DOI: 10.1136/jnnp-2013-307307

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/37224
• Osborne C, Noyce A, Sylvester R (2014). AUTO-REGULATION ICP IN IIH DUE TO CHRONIC CSF LEAK. nameOfConference

  
  

  DOI: 10.1136/jnnp-2014-309236.105

  
  

  QMRO: qmroHref
• Mencacci NE, Isaias IU, Reich MM et al. (2014). Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.. nameOfConference

  
  

  DOI: 10.1093/brain/awu179

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/37203
• Staff TPO (publicationYear). Correction: Bradykinesia-Akinesia Incoordination Test: Validating an Online Keyboard Test of Upper Limb Function. nameOfConference

  
  

  DOI: 10.1371/journal.pone.0105488

  
  

  QMRO: qmroHref
• Osborne C, Stallworthy S, Evanson J et al. (2014). Rapid-onset flaccid paraplegia caused by multiple myeloma dumbbell tumour.. nameOfConference

  
  

  DOI: 10.1136/practneurol-2013-000767

  
  

  QMRO: qmroHref
• Shribman S, Torsney KM, Noyce AJ et al. (2014). A service development study of the assessment and management of fracture risk in Parkinson's disease.. nameOfConference

  
  

  DOI: 10.1007/s00415-014-7333-8

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/42544
• Shribman SE, Torsney K, Noyce AJ et al. (2014). A service development study of the assessment and management of fracture risk in Parkinson's disease. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Torsney KM, Noyce AJ, Doherty KM et al. (2014). A systematic review and meta-analysis of fracture risk in Parkinson's disease. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Torsney KM, Noyce AJ, Doherty KM et al. (2014). Bone health in Parkinson's disease: A systematic review and meta-analysis. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Noyce AJ, Nagy A, Acharya S et al. (2014). Bradykinesia-akinesia incoordination test: validating an online keyboard test of upper limb function.. nameOfConference

  
  

  DOI: 10.1371/journal.pone.0096260

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/37223
• Noyce AJ, Mencacci N, Schrag A et al. (2014). GBA1 and LRRK2 mutations in higher and lower risk subjects from the PREDICT-PD project. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Nalls MA, Saad M, Noyce AJ et al. (2014). Genetic comorbidities in Parkinson's disease. nameOfConference

  
  

  DOI: 10.1093/hmg/ddt465

  
  

  QMRO: qmroHref
• Mencacci NE, Isaias IU, Reich MM et al. (2014). Parkinson's disease in GTP cyclohydrolase-1 mutation carriers. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Shribman SE, Noyce AJ, Martin JE et al. (2014). The distribution of α-synuclein in the enteric nervous system: An immunohistochemical study on colonic resections from 24 control and 4 Parkinson's disease patients. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Nagy A, Noyce A, Lees A et al. (2014). Two cases of abnormal dopamine transporter scan in chorea-acanthocytosis. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Hadavi S, Shribman S, Nagy A et al. (2013). The bradykinesia-akinesia incoordination test: a simple objective test in multiple sclerosis.. nameOfConference

  
  

  DOI: 10.1136/jnnp-2013-306573.184

  
  

  QMRO: qmroHref
• Noyce AJ, Bestwick JP, Silveira-Moriyama L et al. (2014). PREDICT-PD: Identifying risk of Parkinson's disease in the community: methods and baseline results. nameOfConference

  
  

  DOI: 10.1136/jnnp-2013-305420

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/41483
• Dobson R, Yarnall A, Noyce AJ et al. (2013). Bone health in chronic neurological diseases: a focus on Multiple sclerosis and Parkinsonian syndromes.. nameOfConference

  
  

  DOI: 10.1136/practneurol-2012-000435

  
  

  QMRO: qmroHref
• Nagy A, Acharya S, Hadavi S et al. (2013). Bradykinesia-akinesia incoordination test: Validating an online keyboard test of upper limb function. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Djamshidian A, O'Sullivan SS, Foltynie T et al. (2013). Dopamine agonists rather than deep brain stimulation cause reflection impulsivity in Parkinson's disease. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Djamshidian A, O'Sullivan SS, Foltynie T et al. (2013). Dopamine agonists rather than deep brain stimulation cause reflection impulsivity in Parkinson's disease.. nameOfConference

  
  

  DOI: 10.3233/JPD-130178

  
  

  QMRO: qmroHref
• Noyce AJ, Bestwick JP, Silveira-Moriyama L et al. (2013). PREDICT-PD study: Online screening algorithm identifying Parkinson's disease risk. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Noyce AJ, Bestwick JP, Silveira-Moriyama L et al. (2012). Meta-analysis of early nonmotor features and risk factors for Parkinson disease.. nameOfConference

  
  

  DOI: 10.1002/ana.23687

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/48303
• Chan MV, Bubb KJ, Noyce A et al. (2012). Distinct endothelial pathways underlie sexual dimorphism in vascular auto-regulation.. nameOfConference

  
  

  DOI: 10.1111/j.1476-5381.2012.02012.x

  
  

  QMRO: qmroHref
• Noyce AJ, Silveira-Moriyama L, Gilpin P et al. (2012). Severe dysphagia as a presentation of Parkinson's disease.. nameOfConference

  
  

  DOI: 10.1002/mds.24006

  
  

  QMRO: qmroHref
• Doherty KM, Silveira-Moriyama L, Nisbet A et al. (2012). 0854 Camptocormia: what is the cause?. nameOfConference

  
  

  DOI: 10.1136/jnnp-2011-301993.40

  
  

  QMRO: qmroHref
• Noyce A, Silveira-Moriyama L, Lees AJ et al. (2012). A PILOT STUDY OF AN ALGORITHM DESIGNED TO IDENTIFY PARKINSON'S DISEASE IN THE EARLY, NON-MOTOR PHASE. nameOfConference

  
  

  DOI: 10.1136/jnnp-2011-301993.161

  
  

  QMRO: qmroHref
• Noyce A, Bestwick J, Hawkes CH et al. (2012). AN ALGORITHM TO IDENTIFY INDIVIDUALS AT HIGH-RISK OF PARKINSON'S DISEASE IN THE COMMUNITY. nameOfConference

  
  

  DOI: 10.1136/jnnp-2011-301993.162

  
  

  QMRO: qmroHref
• Noyce AJ, Bestwick J, Silveira-Moriyama L et al. (2012). Risk factors and early non-motor features for Parkinson's disease: A systematic review and meta-analysis. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Noyce A, Treacy C, Budu C et al. (2012). THE NEW BRADYKINESIA AKINESIA INCOORDINATION (BRAIN) TEST: AN ONLINE TEST OF UPPER LIMB MOVEMENT. nameOfConference

  
  

  DOI: 10.1136/jnnp-2011-301993.160

  
  

  QMRO: qmroHref
• Acharya S, Nagy A, Budu C et al. (2012). The new bradykinesia akinesia incoordination (BRAIN) test: People with Parkinson's disease versus healthy controls. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Hadavi S, Noyce AJ, Leslie RD et al. (2011). Stiff person syndrome.. nameOfConference

  
  

  DOI: 10.1136/practneurol-2011-000071

  
  

  QMRO: qmroHref
• Noyce AJ, Treacy C, Budu C et al. (2012). The new Bradykinesia Akinesia Incoordination (BRAIN) test: Preliminary data from an online test of upper limb movement. nameOfConference

  
  

  DOI: 10.1002/mds.23947

  
  

  QMRO: qmroHref
• Doherty KM, Noyce AJ, Silveira-Moriyama L et al. (2012). Familial camptocormia: from dystonia to myopathy. nameOfConference

  
  

  DOI: 10.1136/jnnp.2011.246561

  
  

  QMRO: qmroHref
• Noyce AJ, Bestwick J, Hawkes CH et al. (2011). A pilot study of an algorithm designed to identify Parkinson's disease in the early, non-motor phase. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Noyce AJ, Bestwick J, Hawkes CH et al. (2011). An algorithm to identify individuals at high-risk of Parkinson's disease in the community. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Hadavi SY, Bahra M, Noyce AJ et al. (2011). POTENTIAL FOR SERIOUS UNDER-REPORTING OF PRESCRIBING ERRORS BY NEWLY-QUALIFIED DOCTORS. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Noyce AJ, Gilpin P, Howard R et al. (2011). Severe dysphagia preceding Parkinson's disease. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Noyce AJ, McCrae S, Gawler J et al. (2010). Teaching NeuroImages: microhemorrhages resulting from cranial radiotherapy in childhood.. nameOfConference

  
  

  DOI: 10.1212/WNL.0b013e3181e620df

  
  

  QMRO: qmroHref
• Shah M, Deeb J, Fernando M et al. (2009). Abnormality of taste and smell in Parkinson's disease.. nameOfConference

  
  

  DOI: 10.1016/j.parkreldis.2008.05.008

  
  

  QMRO: qmroHref
• Shah M, Deeb J, Fernando M et al. (2007). Taste is abnormal in Parkinson disease and suggests cortical spread. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Noyce AL, Hetley RS, Dobias JJ et al. (2007). Perception of local rigidity due to lines in rotating random-dot textures viewed through an aperture. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Shah M, Deeb J, Fernando M et al. (2007). Taste threshold is abnormal in Parkinson's disease and suggests cortical spread. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Shah M, Noyce A, Deeb J et al. (2006). Chemosensory measurement in essential tremor. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Shah M, Noyce A, Deeb J et al. (2006). Smell identification and taste threshold are normal in essential tremor. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Shah M, Noyce A, Deeb J et al. (2006). Chemosensory measurement in essential tremor. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Noyce A, Shah M, Deeb J et al. (2006). Chemosensory measurement in essential tremor. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref

Supervision

Jonggeol Kim, Global Parkinson's Genetics Programme, Genetic Determinants of Parkinson's Disease

Benjamin Jacobs (subsidiary supervisor), MRC, Genetic Association study in individuals of Diverse Ancestral backgrounds with Multiple Sclerosis (ADAMS)

Alex Zirra, The Medical College of St Bartholomew’s Hospital Trust, Cognitive features of Parkinson’s disease in a diverse population

Ellen Camboe, Barts Charity, Parkinson’s Disease Psychosis in a Diverse Population

Harneek Chohan, Early clinical and biological markers in Parkinson's Disease